Search research articles
Contact Us
Filters
Showing results (31-40 of 133) with videos related to
Page
of 14
Sort By:
NPJ Genomic Medicine
|
February 5, 2021
Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
Chuanliang Cui, Canqiang Xu, Wenxian Yang, et al.
Cell Death & Disease
|
March 16, 2019
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Sifan Yu, Jie Dai, Meng Ma, et al.
Cancer Metastasis Reviews
|
July 2, 2026
HER2 assessment in urothelial carcinoma: standardization challenges and the path forward
Peipei Xie, Yajie Wang, Lei Lu, et al.
Cancer Investigation
|
May 23, 2025
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis
Huichun Tian, Jiaran Zhang, Lili Mao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2019
Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma
Lu Yang, Jie Dai, Meng Ma, et al.
BMC Cancer
|
March 16, 2020
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies
Xinan Sheng, Jie Jin, Zhisong He, et al.
The British Journal of Ophthalmology
|
January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients
Xinan Sheng, Siming Li, Zhihong Chi, et al.
BMC Medicine
|
July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study
Juan Li, Huichun Tian, Huayan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2013
Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib
Jie Dai, Yan Kong, Lu Si, et al.
World Journal of Urology
|
April 2, 2025
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy
Siming Li, Jinchang Wei, Huayan Xu, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 133) with videos related to
Sort By:
Page
of 14
NPJ Genomic Medicine
|
February 5, 2021
Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
Chuanliang Cui, Canqiang Xu, Wenxian Yang, et al.
Cell Death & Disease
|
March 16, 2019
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Sifan Yu, Jie Dai, Meng Ma, et al.
Cancer Metastasis Reviews
|
July 2, 2026
HER2 assessment in urothelial carcinoma: standardization challenges and the path forward
Peipei Xie, Yajie Wang, Lei Lu, et al.
Cancer Investigation
|
May 23, 2025
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis
Huichun Tian, Jiaran Zhang, Lili Mao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2019
Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma
Lu Yang, Jie Dai, Meng Ma, et al.
BMC Cancer
|
March 16, 2020
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies
Xinan Sheng, Jie Jin, Zhisong He, et al.
The British Journal of Ophthalmology
|
January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients
Xinan Sheng, Siming Li, Zhihong Chi, et al.
BMC Medicine
|
July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study
Juan Li, Huichun Tian, Huayan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2013
Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib
Jie Dai, Yan Kong, Lu Si, et al.
World Journal of Urology
|
April 2, 2025
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy
Siming Li, Jinchang Wei, Huayan Xu, et al.
Page
of 14